Hospital-Owned Drug Company Aims for Transparent, Flat Pricing for Critical Generic Drugs

As healthcare organizations struggle to reduce costs and increasingly seek to include price considerations among the value they provide to patients, seven healthcare organizations representing more than 500 U.S. hospitals, together with three major philanthropies that have each committed $10 million to the organization, have developed what they see as a solution to the instability and unpredictability of costs for lifesaving medications.

Read More »